PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Gastrointestinal and Abdominal Radiology 2021; 4(03): 206-213
DOI: 10.1055/s-0040-1722795
Review Article

Imaging of Gastric Carcinoma. Part Two: Lymph node mapping in Gastric Carcinoma

Pulkit Maru
1   Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
,
Bipradas Roy
2   Department of Surgical Oncology, Tata Medical Center, Kolkata, West Bengal, India
,
Saugata Sen
1   Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
,
Argha Chatterjee 
1   Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
› Institutsangaben Funding None.
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Accurate preoperative nodal staging is critical in determining the appropriate therapy and prognosis for stomach cancer. A staging computed tomography should inform the treating surgeon about the nodal burden to decide the appropriate surgical plan or perioperative chemotherapy. Nodal staging is also a powerful predictor of the outcome of surgery and overall survival. Imaging of nodes is also important in the assessment of response following the chemotherapy. In this article, we will discuss lymphatic drainage of stomach and different nodal stations, identification of nodal stations on cross sectional imaging, and different types of surgical nodal clearance for gastric cancer.

Keywords

nodal staging - stomach - cancer - computed tomography


Publikationsverlauf

Artikel online veröffentlicht:
02. März 2021

© 2021. Indian Society of Gastrointestinal and Abdominal Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ferlay J, Soerjomataram I, Dikshit R. et al Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (05) E359-E386
    CrossrefPubMedGoogle Scholar
  • 2 Sano T, Sasako M, Mizusawa J. et al Stomach Cancer Study Group of the Japan Clinical Oncology Group. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg 2017; 265 (02) 277-283
    CrossrefPubMedGoogle Scholar
  • 3 Hochwald SN, Kim S, Klimstra DS, Brennan MF, Karpeh MS. Analysis of 154 actual five-year survivors of gastric cancer. J Gastrointest Surg 2000; 4 (05) 520-525
    CrossrefPubMedGoogle Scholar
  • 4 Kim DY, Seo KW, Joo JK. et al Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 2006; 12 (08) 1182-1186
    CrossrefPubMedGoogle Scholar
  • 5 Gunji Y, Suzuki T, Hori S. et al Prognostic significance of the number of metastatic lymph nodes in early gastric cancer. Dig Surg 2003; 20 (02) 148-153
    CrossrefPubMedGoogle Scholar
  • 6 Ichikura T, Tomimatsu S, Okusa Y, Uefuji K, Tamakuma S. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol 1993; 11 (10) 1894-1900
    CrossrefPubMedGoogle Scholar
  • 7 Amin MB, Edge S, Greene F. et al, eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer 2017
  • 8 Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2005; 2 (02) 98-107
    CrossrefPubMedGoogle Scholar
  • 9 Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995; 82 (03) 346-351
    CrossrefPubMedGoogle Scholar
  • 10 Al-Batran S-E, Homann N, Pauligk C. et al FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 2019; 393 (10184) 1948-1957
    CrossrefPubMedGoogle Scholar
  • 11 Roviello F, Rossi S, Marrelli D. et al Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 2006; 94 (04) 275-280 , discussion 274
    CrossrefPubMedGoogle Scholar
  • 12 Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14 (02) 101-112
    CrossrefPubMedGoogle Scholar
  • 13 Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 2000; 174 (03) 837-844
    CrossrefPubMedGoogle Scholar
  • 14 Kumamoto T, Kurahashi Y, Niwa H. et al True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends. Surg Today 2020; 50 (08) 809-814
    CrossrefPubMedGoogle Scholar
  • 15 Songun I, Putter H, Kranenbarg EM-K, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11 (05) 439-449
    CrossrefPubMedGoogle Scholar